Now showing items 1-6 of 6
CDR2 antigen and Yo antibodies
Paraneoplastic cerebellar degeneration (PCD) is often associated with Yo antibodies that are directed against human cerebellar degeneration-related protein 2 (CDR2). Such antibodies may also be found in ovarian cancer ...
Portal and umbilical venous distribution in the human fetus : a longitudinal ultrasound study
(The University of Bergen, 2007-06-26)
Knowledge of the venous perfusion of the human fetal liver is fragmentary and mainly limited to the umbilical circulation. Current ultrasound technology makes it possible to study blood flow noninvasively and to give new ...
Endometrial carcinoma; can biomarkers aid in the prediction of aggressive disease? A study with focus on preoperative tumour markers
(The University of Bergen, 2012-05-04)
Background: Although endometrial cancer in general has a good prognosis, 15-20% recurs. Surgery is the main treatment with lymph node sampling increasingly advocated as compulsory for adequate staging. In metastatic ...
Fetal splanchnic arteries. A longitudinal study and hemodynamic relations to common Doppler parameters
(The University of Bergen, 2008-05-30)
Although the arterial splanchnic circulation is known to be dynamic and of clinical interest during postnatal life, little is known about its prenatal development and function. We hypothesised that current ultrasound ...
The effects of smoking and hypertensive disorders on fetal growth
(BioMed Central, 2006-04-21)
Background: It is well known that smoking and pregnancy induced hypertension (PIH) are associated with decreased fetal growth. It has been reported that in preeclampsia the fetal growth deficit attributable to smoking ...
Womens' opinions on antenatal care in developing countries: results of a study in Cuba, Thailand, Saudi Arabia and Argentina
(BioMed Central, 2003-05-20)
Background: The results of a qualitative study carried out in four developing countries (Cuba, Thailand, Saudi Arabia and Argentina) are presented. The study was conducted in the context of a randomised controlled trial ...